期刊文献+

microRNAs与三阴型乳腺癌研究进展

暂未订购
导出
出处 《医学研究杂志》 2010年第11期8-10,共3页 Journal of Medical Research
基金 2010年上海市卫生局科研计划(2009113) 上海市重点学科建设项目(B905)
  • 相关文献

参考文献17

  • 1William J,Irvin Jr,Lisa A,et al.What is triple-negative breast cancer? Eur J Cancer,2008,44(18):2799-2805.
  • 2Herschkowitz JI,Simin K,Weigman VJ,et al.Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.Genome Biol,2007,8(5):R76.
  • 3Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Clin Cancer Res,2004,10(16):5367-5374.
  • 4Chuang JC,Jones PA.Epigenetics and microRNAs.Pediatric Research,2007,61(5 Pt 2):24R-29R.
  • 5Colleoni M,Gelber S,Goldhirsch A,et al.Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer:International Breast Cancer Study Group Trial 13-93.J Clin Oncol,2006,24(9):1332-1341.
  • 6Pritchard KI,Shepherd LE,O' Malley FP,et al.HER2 and responsiveness of breast cancer to adjuvant chemotherapy.N Engl J Med,2006,354(20):2103-2111.
  • 7Piccant-Gebhart MJ,Procter M,Leyland-Jones B,et al.Trastuzumad after adjuvant chemotherapy in HER-2-positive breast cancer.N Engl J Med,2005,353(16):1659-1672.
  • 8Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer:clinical features and patterns of recurrence.Clin Cancer Res,2007,13(15):4429-4434.
  • 9袁中玉,王树森,高岩,苏争艳,罗文标,管忠震.305例三阴乳腺癌患者的临床特征及预后因素分析[J].癌症,2008,27(6):561-565. 被引量:161
  • 10Lee Y,Kim M,Han J,et al.MicroRNA genes are transcribed by RNA polymerase Ⅱ.EMBO J,2004,23(20):4051-4060.

二级参考文献19

  • 1Perou C M, Sorlie T, Eisen M-B, et al. Molecular portraits of human breast tumors [J]. Nature, 2000,406(6797) :747-752.
  • 2van't Veer L J, Dai H, van de Vijver M J, et al. Gene expression profiling predicts clinical outcome of breast cancer [J ]. Nature, 2002,415(6871 ) : 530-536.
  • 3Sotiriou C, Neo S Y, McShane L M, et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study [J]. Proc Natl Acad Sci USA, 2003,100(18) : 10393-10398.
  • 4Rakha E A, El-Sayed M E, Green A R, et al. Prognostic markers in triple-negative breast cancer [J]. Cancer, 2007, 109( 1 ) : 25-32.
  • 5Jones C, Nonni A V, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation [ J ]. Br J Cancer, 2001,85 ( 3 ) : 422-427.
  • 6Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J]. Clin Cancer Res, 2004, 10 (16) :5367-5374.
  • 7Banerjee S, Reis-Filho J S, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J]. J Clin Pathol, 2006,59(7):729-735.
  • 8Carey L A, Dees E C, Sawyer L, et al. The triple negative paradox : primary tumor chemosensitivity of breast cancer subtypes [J]. Clin Cancer Res, 2007,13(8) :2329-2334.
  • 9Chu K C, Lamar C A, Freeman H P. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment [J]. Cancer, 2003, 97( 11 ) : 2853-2860.
  • 10Cunningham J E, Butler W M. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis [ J ]. Breast Cancer Res Treat, 2004,88 (2) : 161-176.

共引文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部